insights_auto
Why is ARGX down 10.86%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
$827.58
arrow_downward
-10.86%(-100.86) 1D
Oct 8, 9:30:46 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$831.71
High
$832.24
Low
$820.76
Mkt. cap
52.57B
Avg. vol.
263.56K
Volume
108.87K
P/E ratio
31.44
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
Open
$831.71
High
$832.24
Low
$820.76
Mkt. cap
52.57B
Avg. vol.
263.56K
Volume
108.87K
P/E ratio
31.44
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
argenx (ARGX) Shares Drop 14.2% Pre-Market Amid Market Uncertain
Yahoo Finance
·
1 hour ago
Why Is ARGX Stock Plunging Today?
Benzinga
·
1 hour ago
Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR